Pathway Capital Management, LP Denali Therapeutics Inc. Transaction History

Pathway Capital Management, LP

  • $29.4 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024
BUY
$16.2 - $23.18 $1.13 Million - $1.61 Million
69,450 New
69,450 $1.49 Million
Q4 2021

Feb 10, 2022
SELL
$42.59 - $55.02 $43.1 Million - $55.7 Million
-1,012,240 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$48.48 - $78.23 $49.1 Million - $79.2 Million
1,012,240 New
1,012,240 $51.1 Million

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Pathway Capital Management, LP Portfolio

Follow Pathway Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email